|
|
||||||||
J Thorac Cardiovasc Surg 1998;116:943-948
© 1998 Mosby, Inc.
GENERAL THORACIC SURGERY |
From the Department of Cardiovascular and Thoracic Surgery, Georgetown University Medical Center, and the National Cancer Institute, Washington, DC.
Read at the Seventy-eighth Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 3-6, 1998.
Received for publication May 8, 1998. Revisions requested July 31, 1998; revisions received Sept 10, 1998. Accepted for publication Sept 16, 1998. Address for reprints: Farid Gharagozloo, MD, Department of Cardiovascular and Thoracic Surgery, Georgetown University Medical Center, 3800 Reservoir Rd NW, Washington, DC 20007.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
All patients underwent culture-specific antimicrobial therapy until the removal of the drainage catheters. All patients received enteral alimentation either orally or with the use of nasoduodenal feeding tubes. After discharge from the hospital, the patients were followed up with chest radiographs and blood tests at 7 days and 1 month and with chest computed tomographic scans at 6 months and 1 year.
Bronchoscopy was performed in patients in whom a recurrent BPF was suspected.
| Results |
|---|
|
|
|---|
| Discussion |
|---|
|
|
|---|
Many preoperative factors increase the risk of PNE. Increased age and male sex increase the incidence.
16 The majority of our patients were elderly men. Preoperative radiation is a risk factor, presumably by decreasing the vascular supply to the bronchus. Three patients in our series had undergone preoperative radiotherapy. Poor preoperative nutritional state and the use of steroids can impede healing and increase the risk of BPF. Five patients in this series either were malnourished or were on a regimen of prolonged steroid therapy. Active infection in the form of resection in the face of inflammatory conditions, bronchiectasis, presence of postobstructive pneumonitis, gross contamination of the pleural space, and sputum cultures positive for tuberculosis increases the risk of PNE.
17-19 Fourteen patients in the present report had either postobstructive pneumonitis or bronchiectasis.
Technical factors also play a significant role in increasing the risk of PNE. A long bronchial stump can be the site of stagnation of sputum and breakdown as the result of secondary infection. Residual tumor and devascularization of the bronchial stump and excessive tension on the bronchial closure can lead to breakdown of the stump and PNE.
18-20 In 17 of the 22 patients, a long bronchial stump was seen at re-exploration.
The best means of decreasing the morbidity and mortality associated with BPF is prevention. The bronchial stump needs to be handled carefully. Excessive length and devascularization of the stump should be avoided. In patients with predisposing risk factors, the bronchial stump should be reinforced with vascularized tissue in the form of the omentum, pericardial fat pad pedicle, or chest wall muscle. After prevention, a high index of suspicion and an aggressive approach to the diagnosis play a significant role in decreasing the morbidity and mortality of PNE.
The management of PNE has ranged from tube thoracostomy to open pleural drainage to thoracoplasty.
20-24 Unfortunately many of the approaches in the past have ignored the well-established rules for the treatment of any infected space. Furthermore, the treatment protocols have not accounted for a potential difference in the pathophysiology of early versus late PNE. In 1963, a landmark paper by Clagett and Geraci
22 described a technique for the management of PNE that was based on sound surgical principles for the treatment of an abscess. The 2-stage procedure consisted of open pleural drainage, closure of the BPF, removal of the necrotic tissue, and secondary closure or obliteration of the pleural cavity with antibiotic solution. The Clagett procedure has been reported to be effective in 88% of patients, with failures resulting from persistent or recurrent BPF.
21 In an attempt to address these failures, Pairolero and Arnold
24 described the transposition of well-vascularized extrathoracic muscle as an intermediate step before obliteration of the pleural cavity with antibiotic solution. This modification of the "Clagett" procedure was designed to further reinforce the bronchial stump and to decrease the size of the pleural cavity. The success of the Pairolero modification of the "Clagett" procedure has been 83.9%.
7 The Pairolero modification remains our procedure of choice for late PNE. Although this procedure is associated with excellent success, it requires prolonged hospitalization, repeated dressing changes and operations, and significant morbidity.
Pleural space irrigation has been advocated as an alternate means of treating empyema and pneumonectomy space infection.
25,26 Although this technique has had reasonable promise, it has been hampered by the lack of a uniform approach, small groups of patients, a varied patient population, and high failure rates. In an attempt to decrease the morbidity and hospitalization for the subset of patients with early PNE, we explored the technique of pleural space irrigation as a further modification of the "Clagett" procedure. We hypothesized that the most likely cause of early PNE is a combination of technical errors in handling the bronchus or the result of delayed healing from the predisposing factors. It would follow then that a technically satisfactory reclosure of the bronchus, debridement of the acutely infected pleural space, and control of contamination by an irrigation system may be comparable to open packing and mechanical control of the contaminated space. Inasmuch as there was no recurrence of BPF or empyema, pleural space irrigation followed by obliteration of the pleural space with an antibiotic solution may represent an ideal treatment option for patients with early PNE with a small BPF. This modification of the Clagett procedure requires 1 surgical procedure and results in significantly shorter hospitalization and decreased morbidity in this selected subset of patients with PNE.
| Appendix: Discussion |
|---|
|
|
|---|
First, successful drainage of an infected pleural space is dependent on the age of the infection. Those empyemas that are only a few days old are associated with an effusion that is more a transudate than an exudate. As a result, simple tube drainage is effective and the addition of pleural space irrigation, while generally not necessary, certainly facilitates healing. In contrast, when the empyema is a few weeks old, the effusion is thick, tenacious, and associated with a woody, indurated pleura. Simple drainage and irrigation in this chronic situation simply does not work. Instead, debridement is necessary to remove the exudate before healing of the pleura can begin.
Dr Gharagozloo, can you describe in greater detail for us what the local conditions may be that may want to force you into leaving an open window. I believe it is more than just the age of the empyema.
Second, of the 3 things, BPFs can range in size from those so small that they cannot be visualized to those that involve the entire width of the bronchus. Simple drainage of an early empyema with a pinhole fistula will heal the fistula in every case. In contrast, if the bronchus has dehisced at the level of the carina, a complete suture reclosure may be impossible without some type of tissue reinforcement.
Third, the pleural space must be obliterated if the fistula is to eventually heal. Dr Jim Clagett in his report to this Association in 1963, clearly demonstrated, and we all have come to follow, that obliteration with antibiotic solution has been the method of choice. In the authors' collective review, the fistulas were small, the empyemas early, and the cavities obliterated with antibiotic solution. One would predict that the results would be excellent, but 100% is indeed outstanding. However, I still want to caution that larger BPFs associated with older empyemas may not fare as well.
Dr Gharagozloo. Thank you for your comments, Dr Pairolero. The answer to your question rests in the quality of the tissues. When I was a fellow under you, I learned that lesson and I think it is a very important point: If you find woody, indurated tissue on opening the patient, you should not institute the irrigation system. In many of these patients, a simple mechanical debridement followed by the combination of the povidone-iodine irrigation, which is also an antibiotic as well as a mechanical system, works quite well. However it is the experience of the surgeon in picking which patients should be treated in which way that makes the difference.
Dr Joseph S. Ladowski (Fort Wayne, Ind). I would like to offer a caution and ask one question. Our tertiary care referral center has cared for far fewer of these patients in a similar fashion, and we have seen a patient go from mild renal dysfunction to dialysis dependence with the installation of 160 mg of gentamicin plus a gram of neomycin into the pleural space. That is the caution.
The question is this: Have you quantified the absorption of these very nephrotoxic antibiotics from the pleural space? Perhaps if the fluid is truly Gram stain negative you may want to use systemic antibiotics instead.
Dr Gharagozloo. I appreciate the comments. We have learned over the years that systemic antibiotics probably do not have a major role in dealing with this situation. This is a local situation that needs to be treated in a local fashion.
As far as the placement of DAB solution in the pleural space, certainly there can be absorption. We have not looked at it. I think that's well established, that there is absorption and certainly that risk is there. The other risk is with the irrigation system. As you know, we have gone down to significantly lower levels of povidone-iodine because of the povidone-iodine toxicity that is seen with mediastinal irrigation systems and so forth.
I agree with the cautions. In our experience, when we check the Gram stain on these patients, the organisms seem to be a hodgepodge because of the presence of a BPF. Trying to do specific organism-focused treatment by intravenous antibiotics would probably not be wise in this setting.
Dr Walter Klepetko (Vienna, Austria). If you assume that the irrigation system has contributed significantly to your success and you are irrigating with an amount of 40 mL/h, one would expect that the fluid is only in the posterior part of the chest. Do you think it is important that it is distributed all over the thoracic cavity? In that case do you request that your patients frequently change their position?
In our limited experience with a similar procedure, we have also had success in a patient who had already had 2 surgical attempts at closure of a large bronchial stump fistula. In that patient we found a very thick pleura, and we found it essential to take all the pleura off, as in an extrapleural pneumonectomy, with all the necrotic tissue. How aggressively are you performing the debridement?
Dr Gharagozloo. We are talking about early PNE. A patient with a condition such as you described would not be treated in this way, because that patient would need repeated debridement by mechanical means and basically the various other modifications of Clagett procedure. I would term that patient's condition late PNE. Even if the presentation were early, as Dr Pairolero mentioned, the time is not important; it is what the surgeon sees in the pleural space that is important. That is key.
I have often wondered whether higher amounts of this irrigation system would be better, because it would obviously distribute better throughout the pleural space. That would be an interesting study to do if we had the patients with whom to do it.
The 40 comes from the experience with the mediastinum. We try to put these catheters in the mediastinum in the back of the chest such that there are many holes and all of the chest basically bathes with this fluid. However, I think a higher level might be better. That would be something to check out in the future.
Dr Klepetko. Deriving from a small experience with 4 cases of late PNE treated in a similar way, I think you should be more confident in your method, and I think you could also use it in late PNE.
Dr Gharagozloo. Thank you.
Dr Joseph I. Miller, Jr (Atlanta, Ga). You have just described the most extensive experience ever reported with the best success rate in the treatment of early PNE. When this was originally reported by Dr Clagett with Dr Geraci in 1966 and then later reported by Stafford in the mid-80s from the Mayo Clinic, their success rate there was 76%. They reported that if you had a single organism you had a much higher success rate than if you had a mixed organism, particularly if you had a Gram negative organism.
I am not sure that I can understand how you achieved a 100% success rate when Dr Pairolero and the others and I have been trying for 25 years to obliterate the problem. I would ask 3 questions.
To what do you attribute your success when, despite all the efforts of others, no one has been able to attain that?
Second, the original Clagett solution was BAN, Bacitracin, Aerosporin, and neomycin. You've used the acronym DAB. I understand the concentrations are lower, but I am curious about DAB, because your drugs are gentamicin, neomycin, and polymyxin B. Have you had any problems with the toxicity?
Dr Gharagozloo. Thank you for your comments. If you look at Dr Clagett's paper and then the subsequent papers that he published, the reason the Clagett procedure failed was that the bronchus broke down; there was a recurrence of a BPF that made things fail. Dr Pairolero's modification of that procedure is very much meant to deal with that problem, which is to put a vascularized muscle on top so that the bronchus does not fall apart; if you look at that, the numbers get better.
One key in our procedure was that we switched from using polypropylene (Prolene; Ethicon, Inc, Somerville, NJ), which is what I had learned and used in the years previous to this study, to something that is absorbed so there is no material in the pleural space that is foreign and perhaps acts to cause infection. Another key is to close that bronchus and to deal with these patients very early.
DAB is a term that I carry with me from the Mayo Clinic. It stands for debridement antibiotic solution.
Dr Victor F. Trastek (Rochester, Minn). I have 2 questions. What role do you think the negative Gram stain plays? If you do not get a negative Gram stain after 2, 3, or 4 weeks, what do you do?
Dr Gharagozloo. In that case we would convert to the typical operation—open packing and so forth.
Dr Trastek. You would not continue with closed treatment if the Gram stain remained positive?
Dr Gharagozloo. No, I do not think that would be appropriate.
Dr Stanley C. Fell (Bronx, NY). You have just said that you use an absorbable suture, but in the text you say a nonabsorbable monofilament suture. What suture do you use? What is the brand name?
Dr Gharagozloo. It is absorbable suture, it is monofilament, and it is PDS polydioxanone (Ethicon).
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Schneiter, T. Grodzki, D. Lardinois, P. B. Kestenholz, J. Wojcik, B. Kubisa, J. Pierog, and W. Weder Accelerated treatment of postpneumonectomy empyema: A binational long-term study J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Molnar Current surgical treatment of thoracic empyema in adults Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 422 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lang-Lazdunski Closure of a bronchopleural fistula after extended right pneumonectomy after induction chemotherapy with BioGlue surgical adhesive J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1497 - 1498. [Full Text] [PDF] |
||||
![]() |
D. Chichevatov and A. Gorshenev Omentoplasty in Treatment of Early Bronchopleural Fistulas after Pneumonectomy Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 211 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gossot, J.-B. Stern, D. Galetta, D. Debrosse, P. Girard, R. Caliandro, L. Harper, and D. Grunenwald Thoracoscopic management of postpneumonectomy empyema Ann. Thorac. Surg., July 1, 2004; 78(1): 273 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schneiter, P. Cassina, S. Korom, I. Inci, M. Al-Abdullatief, A. Dutly, P. Kestenholz, and W. Weder Accelerated treatment for early and late postpneumonectomy empyema Ann. Thorac. Surg., November 1, 2001; 72(5): 1668 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Regnard, M. Alifano, P. Puyo, E. Fares, P. Magdeleinat, and P. Levasseur Open window thoracostomy followed by intrathoracic flap transposition in the treatment of empyema complicating pulmonary resection J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |